Characteristic | (N = 367) |
---|---|
Age, mean (SD), y | 59.4 (16.5) |
Age category, n (%) | |
≥ 65 years | 152 (41.4) |
≥ 75 years | 75 (20.4) |
Gender, n (%) | |
Male | 165 (45.0) |
Female | 202 (55.0) |
Race, n (%) | |
White/Caucasian | 304 (82.8) |
Black/African American | 50 (13.6) |
Asian | 3 (0.8) |
Othera | 4 (1.1) |
Unknown | 6 (1.6) |
Ethnicity, n (%) | |
Hispanic/Latino | 71 (19.4) |
Presence of a caregiver, n (%) | 166 (45.2) |
Place of Residence, n (%) | |
Home | 303 (82.6) |
Assisted living | 35 (9.5) |
Skilled nursing facility | 29 (7.9) |
Primary diagnosis, n (%) | |
Dementia | 134 (36.5) |
Stroke | 113 (30.8) |
TBI | 120 (32.7) |
Concomitant medications at baseline (total no. of medications) | |
Mean | 7.7 |
Median (min, max) | 7.0 (0, 27) |
Psychopharmacologic medication use,b n (%) | 260 (70.8) |
Any antidepressant | 178 (48.5) |
SSRIs | 103 (28.1) |
Other | 83 (22.6) |
Non-selective (tricyclic) | 14 (3.8) |
Sedative/hypnotics/anxiolytics | 124 (33.8) |
Any benzodiazepinec | 109 (29.7) |
Antipsychoticsd | 66 (18.0) |
Anticonvulsants | 92 (25.1) |
CNS-LS scoree,f | |
Mean (SD) | 20.5 (4.4) |
Median (min, max) | 20 (13, 34) |
PBA episode count (over 7 days prior to baseline)f | |
Mean (SD) | 21.4 (25.0) |
Median (min, max) | 12 (0, 240) |
MMSE score, mean (SD)f | 23.9 (5.9) |
QOL-VAS, mean (SD) | 5.9 (2.6) |
PHQ-9,g mean (SD) | 13.5 (5.9) |